Antibiotic Therapy for Bacterial Prostatitis
Fluoroquinolones are the first-line treatment for bacterial prostatitis due to their favorable pharmacokinetic profile and broad-spectrum coverage against common causative pathogens. 1
Classification and Pathogens
Bacterial prostatitis is classified into two main types:
Acute Bacterial Prostatitis (ABP)
- Primarily caused by Enterobacterales 2
- Presents with fever, perineal pain, and urinary symptoms
Chronic Bacterial Prostatitis (CBP)
First-Line Treatment Recommendations
For Chronic Bacterial Prostatitis:
- Fluoroquinolones (preferred first-line agents):
For Specific Pathogens:
Chlamydia trachomatis:
- Azithromycin 1.0-1.5 g single dose OR
- Doxycycline 100 mg twice daily for 7 days 1
Mycoplasma genitalium:
- Azithromycin 500 mg on day 1, then 250 mg for 4 days
- For macrolide-resistant strains: Moxifloxacin 400 mg daily for 7-14 days 1
Ureaplasma urealyticum:
- Doxycycline 100 mg twice daily for 7 days OR
- Azithromycin 1.0-1.5 g single dose 1
Treatment Duration
- Acute bacterial prostatitis: 2-4 weeks 6
- Chronic bacterial prostatitis: 4-6 weeks, may be extended to 6-12 weeks if improvement occurs 1, 6
Clinical Considerations
Diagnosis:
- Proper diagnosis is essential before initiating antibiotics
- For CBP, the Meares and Stamey 2- or 4-glass test is recommended 1
Treatment efficacy:
Potential complications:
- Consider prostatic abscess in patients not responding to antibiotics
- Transrectal ultrasound may be necessary to rule out abscess 1
Relapse prevention:
- Long-term suppressive antibiotic therapy may be useful in selected patients with recurrent bacteriuria 6
Common Pitfalls to Avoid
- Initiating antibiotics without proper microbiological diagnosis
- Inadequate treatment duration leading to recurrence
- Overlooking non-bacterial causes of prostatitis symptoms
- Failing to treat sexual partners in cases of sexually transmitted infections 1
Treatment Outcomes
Studies comparing fluoroquinolones have demonstrated similar efficacy:
- Levofloxacin vs. ciprofloxacin showed comparable clinical success rates (75% vs 72.8%) and microbiological eradication rates (75% vs 76.8%) 5
- Ciprofloxacin has shown excellent results particularly for E. coli prostatitis, with eradication rates of 92% at 3 months and 70-80% at 12-24 months 7
Fluoroquinolones are preferred due to their excellent penetration into prostatic tissue and broad-spectrum activity against both gram-negative and gram-positive organisms commonly implicated in bacterial prostatitis.